Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.34 |
| ▸ | PRKCA | P17252 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29610284 | 1.00 | NAAA (0.49) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| SCHEMBL471135 | 1.00 | NAAA (0.49) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| SCHEMBL30741 | 1.00 | NAAA (0.49) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| SCHEMBL9577723 | 1.00 | NAAA (0.49) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| SCHEMBL1332303 | 1.00 | NAAA (0.49) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| SCHEMBL13800607 | 1.00 | NAAA (0.49) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| Ammonia Solution, Strong SCHEMBL17962463 | 0.98 | NAAA (0.47) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| Ammonia Solution, Strong SCHEMBL8373756 | 0.98 | NAAA (0.47) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| SCHEMBL6630631 | 0.98 | NAAA (0.47) | NAAAGAASMN1; SMN2EPHX2PRKCA | |
| SCHEMBL315239 | 0.98 | GAA (0.49) | NAAAGAASMN1; SMN2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617955-B2 | Additive production process with a thermoplastic radically cross-linkable construction material | STRATASYS, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-07 | — | — | US | disclosed |
| US-12447699-B2 | Anisotropic composite materials based on polyisocyanates | COVESTRO DEUTSCHLAND AG (DE) | 2025-10-21 | — | — | US | disclosed |
| US-12331214-B2 | Resistant 2K-PUR coatings | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2025-06-17 | — | — | US | disclosed |
| EP-3994192-B1 | RESISTANT 2K-PUR COATINGS | COVESTRO DEUTSCHLAND AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| US-20240294798-A1 | Coating Agents and Coatings That Are Obtainable Therefrom and Have Improved Resistance to Soiling and (Self-) Cleaning Properties | COVESTRO DEUTSCHLAND AG (DE) | 2024-09-05 | — | — | US | disclosed |
| US-20240294797-A1 | Coating Compositions and Coatings Obtainable Therefrom Having Improved Soiling Resistances and (Self-) Cleaning Properties | COVESTRO DEUTSCHLAND AG (DE) | 2024-09-05 | — | — | US | disclosed |
| US-12036737-B2 | Film areas functionalized by means of 3D printing for finishing workpiece surfaces | STRATASYS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| EP-4359459-A1 | COATING AGENTS AND COATINGS THAT ARE OBTAINABLE THEREFROM AND HAVE IMPROVED RESISTANCE TO SOILING AND (SELF-)CLEANING PROPERTIES | Covestro Deutschland AG (DE) | 2024-05-01 | — | — | EP | disclosed |
| EP-4359461-A1 | COATING COMPOSITIONS AND COATINGS OBTAINABLE THEREFROM HAVING IMPROVED SOILING RESISTANCES AND (SELF-)CLEANING PROPERTIES | Covestro Deutschland AG (DE) | 2024-05-01 | — | — | EP | disclosed |
| WO-2016170060-A1 | PROCESS FOR PRODUCING POLYISOCVANURATE PLASTICS HAVING FUNCTIONALIZED SURFACES | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170058-A1 | PROCESS FOR PRODUCING POLYISOCYANURATE PLASTICS | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170057-A1 | SOLIDS BASED ON POLYISOCVANURATE POLYMERS PRODUCED UNDER ADIABATIC CONDITIONS | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170059-A1 | POLYISOCYANURATE POLYMERS AND PROCESS FOR THE PRODUCTION OF POLYISOCYANURATE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170061-A1 | POLYISOCYANURATE PLASTICS HAVING HIGH THERMAL STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| EP-0463754-A1 | Stabilization of glutarimide polymers | ROHM AND HAAS COMPANY (US) | 1992-01-02 | — | — | EP | disclosed |
| EP-0213484-A1 | Alpha-Hydroxy-beta-2,2,6,6-tetramethyl piperidyl ethylene oxiranes as light and heat stabilizers for polyvinyl chloride resins | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1987-03-11 | — | — | EP | disclosed |
| US-4362831-A | A HINDERED AND HETEROCYCLIC AMINE WITH A THIOALKANOIC ACID AMIDE | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1982-12-07 | — | — | US | disclosed |
| EP-0007460-B1 | FLAME-RETARDANT POLYMER COMPOSITIONS | CIBA-GEIGY AG (CH) | 1982-09-15 | — | — | EP | disclosed |
| EP-0007460-A1 | Flame-retardant polymer compositions | CIBA-GEIGY AG (CH) | 1980-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617955-B2 | Additive production process with a thermoplastic radically cross-linkable construction material | UBE2G2, MTCL3, RAD51 | NAAA 4654/4885GAA 3015/4885SMN1; SMN2 754/4885 |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | TST, C9, ESD | NAAA 1125/4885GAA 4760/4885SMN1; SMN2 4765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.